Everything You Need to Know Before Trying CoolTone, the Newest Body Contouring Device

By Katie Berohn for Good Housekeeping
February 18, 2021 Original Article >

The before-and-afters are pretty crazy.

Many years ago, I’d all but resigned myself to the fact that I would never have visible abs. No matter how many lower ab workouts I did or miles I ran, I just couldn’t get even the faintest outline of an oblique to poke through my skin. I’d accepted it — my abs would exist somewhere in my midriff, hidden from view from the rest of the world. That is, until I heard about CoolTone, a new body contouring innovation from Allergan.

CoolTone is a noninvasive treatment that helps tone muscles via the equivalent of over 2,000 sit ups in just 30 minutes — while lying down. Sound too good to be true? I thought so too, so I went to Ellen Marmur, M.D., board-certified dermatologist and founder of MMSkincare to try the treatment out for myself, and to get her expert advice.

What exactly is CoolTone?

“CoolTone is a device that you put on either your stomach muscles, your thigh muscles, or your butt muscles,” to quickly and efficiently strengthen those areas, Dr. Marmur says. “It gets your muscles to contract. You can basically be doing 2,200 sit ups in 30 minutes, or the same number of contractions on your butt or thighs.”

Essentially, in 30 minutes, you’ll be getting the kind of workout that Olympic athletes get on a daily basis and us normal folk can only dream of. For best results, it’s recommended to do a series of four treatments within two weeks.

How does CoolTone work?

CoolTone uses magnetic muscle stimulation to recruit muscle cells to contract. When doing sit-ups yourself, “you’re really only using a quarter to a half of your muscle,” says Dr. Marmur. “Most normal humans can’t recruit their entire muscle belly. This machine basically does that for us. Rather than us doing 2,200 sit ups, and only using 25% of our muscle, it’s actually recruiting 100% of the muscle belly … so you’re going to get a better workout.” Read Original Article >